SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (1195)7/8/2005 11:19:22 PM
From: Jibacoa  Read Replies (1) | Respond to of 3722
 
ARIA Also was up more than 8% on volume of more than 1.455M It was initiated this week by BAC with a "buy" rating.<g>

bigcharts.marketwatch.com

It had a 58% increase in revenues in its March Q but the loss was almost double ($0.23/shr vs. $0.13/shr in 2004) and the EL for 2005 is up to $0.90/shr vs. $0.69/shr in 2004

On May 18 at ASCO it announced the results of its PII of mTOR inhibitor, AP23573,which showed "striking clinical benefit and symptomatic improvement" in patients with advanced sarcoma. And later in the month it announced a PIa on oral administration of AP23573, which has been assigned a "fast track" designation by the FDA (for whatever that is worth under its new Oncology Head, Dr.Richard Padzur <g>)

And on June 30 it announced that it was starting a PII of its AP23573 on patients with recurrent or persistent endometrial Ca.

Bernard



To: Jibacoa who wrote (1195)8/24/2005 12:51:36 AM
From: Jibacoa  Respond to of 3722
 
ALKS Also had a good upgap and was able to close above its August 5 H of 16.75

It was up 11.62% on volume of 7,508,710 although it showed some weakness in AHs trading.<g>

bigcharts.marketwatch.com

The stock was able to make a 52 wks. H and it also closed above its April 2004 H of 17.18 It has now fully closed its June 2002 downgap but it is still far from testing its March 2002 H at 31.38 <g>

bigcharts.marketwatch.com

It received an upgrade from Bear Sterns and some other good comments today.

forbes.com

marketwatch.com

Bernard